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Massive digoxin overdosage is an uncommon but serious medical emergency
with a mortality of 20%.1 It involves multiple management problems including
hyperkalaemia, heart block and resistant ventricular arrhythmias. The manage-
ment of the problems associated with severe digoxin overdosage has been
assisted by two recent therapeutic advances, the use of digoxin-specific antibody
fragments (Fab) to reverse toxicity,2-4 and the relatively new Vaughan-Williams
Class III antiarrhythmic, amiodarone, which has been of value in controlling the
arrhythmias.45 We report a case of severe digoxin poisoning in which both these
agents were employed with a favourable outcome.
CASE HISTORY
A 41-year-old schizophrenic woman, who had been under treatment for a
suspected cardiomyopathy, was admitted to hospital following the ingestion, in a
suicidal attempt, of approximately one hundred 0.25mg tablets of digoxin and a
small quantity of thioridazine. Forced emesis and gastric lavage were performed
less than three hours after the patient claimed she had ingested the tablets, but
none were recovered. Serum digoxin concentrations subsequently became
available and revealed a level of 22 pg/I on admission (therapeutic range 1 - 2
pg/1), rising to 32 pg/l twelve hours later.
On initial examination the patient was alert and orientated, with a pulse rate
of 60/minute and a blood pressure of 100/60 mmHg, which subsequently fell
to 80/60 mmHg. Cardiac monitoring showed variable atrio-ventricular block
developing with an atrial rate of 120/minute and a ventricular rate ranging from
35 to 120/minute. The typical ST segment changes attributable to digoxin were
also present. A bipolar transvenous ventricular pacing wire was inserted and
connected to an external pacemaker (Devices Limited, England). Satisfactory
pacing was achieved with an output of 3 volts, rate 80/minute on demand
setting. Systolic blood pressure remained low at 80 mmHg despite dobutamine
infusion, but a good urinary output was maintained.
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The serum potassium concentration on admission was 5.0 mmol/l butfour hours
later this had risen to 6.4 mmol/l and an intravenous bolus of 50ml of 50%
dextrose and 10 units of monocomponent porcine insulin ('Actrapid', Novo) was
administered. Hyperkalaemia persisted, the serum potassium concentration
reaching apeak value of 7.3 mmol/l, but wassuccessfully controlled bydextrose/
insulin therapy, a total of ten doses being administered over a 40 hour period.
(Fig 1).
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Thirty-six hoursafter admission thefirstepisodeofventricularfibrillation occurred
- there had been no premonitary arrhythmias - and proved resistant to
conventional therapy with DC conversion using energy levels up to 400J, both
alone and following intravenous sodium bicarbonate and lignocaine. Six
unsuccessful defibrillation attempts were made, but paced rhythm, with cardiac
output, was eventually restored by a seventh 400J DC shock preceded
by 300mg amiodarone intravenously. Continuous infusion of amiodarone
0.4mg/min was then commenced. The patient remained unconscious but
respiration was spontaneous. Despite the amiodarone infusion, ventricular
fibrillation recurred three hours later. On this occasion five 400J DC shocks,
sodium bicarbonate and a further 150mg bolus of amiodarone were required to
convert to paced rhythm. An hour later the patient arrested a third time and was
even more difficult to resuscitate, a further 300mg bolus of amiodarone and
twelve 400J DC shocks being required. After this arrest the infusion rate was
increased to 0.6mg/minute and intermittent positive pressure ventilation
instituted as spontaneous respiration had not returned.
Following the first episode of ventricular fibrillation, arrangements were made to
obtain digoxin-specific antibody fragments (Fab) from the National Poisons
Information Service, New Cross Hospital, London.2 Four hours after the third
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cardiac arrest, 320mg of these fragments were infused over a period of 40
minutes. The dose (to the nearest 40mg) was calculated using the following
formula involving the weight of the patient and the most recent serum digoxin
concentration: dose = 60 x 0.0056 x body weight (kg) x CPSS digoxin (g/l),
(CPSS = concentration in plasma at steady state, more than 6 hours post
ingestion). Within an hour of starting the infusion there was a dramatic improve-
ment in both electrical and clinical parameters: the ECG returned to sinus rhythm
with a normal PR interval, so that demand pacing was no longer needed. Her level
of consciousness improved and the onset of spontaneous respiration permitted
removal of the endotracheal tube. During the next few hours, serum potassium
concentration fell to 3.3 mmol/l. An intravenous infusion of potassium chloride
was instituted and a total of 100 mmol potassium chloride administered over the
subsequent 15 hours. Twenty-four hours later, transient Wenckebach-type
second degree heart block was noted; this responded to intravenous atropine.
The effect ofthe Fab fragment infusion on the total and free serum digoxin levels
is illustrated in Fig 2. Over the next few days the patient continued to improve
and was able to return to psychiatric care within a week of admission.
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DISCUSSION
Digoxin-specific antibody fragments remove digoxin from tissue binding sites
and combine with circulating free digoxin.2 The pharmacologically inactive
complex of Fab and digoxin has a more rapid rate of excretion than the drug
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alone, but more importantly the toxic effect of digoxin on the myocardial cell is
rapidly removed.6 The resultant effect is well illustrated by the total and free
digoxin levels.
Amiodarone has proved beneficial in the management of digoxin-induced
arrhythmias, where conventional agents such as lignocaine, phenytoin and
procainamide and beta-adrenergic blocking drugs have been ineffective4 5
though we felt the latter would have been inappropriate in the presence of
atrioventricular block. The mode of action of amiodarone, and the reason for its
efficacy in treating these arrhythmias is uncertain. It has been shown that
amiodarone increases the serum digoxin concentration, possibly by displacing
digoxin from myocardial binding sites.7
Hyperkalaemia occurs in massive digoxin poisoning as a result of inhibition ofthe
sodium-potassium activated adenosine triphosphatase (Na-K ATPase) pump in
the cell membrane which is responsible for maintaining a high intracellular level
of potassium.8 It has been shown that the development of significant
hyperkalaemia in digoxin poisoning is a bad prognostic indicator,9 and usually
occurs in cases where the digoxin level is particularly high, although a direct
correlation between digoxin concentration and potassium concentration has not
been shown. Even in the presence of hyperkalaemia there is usually a total body
deficit of potassium; hence, following treatment with Fab fragments, the
reactivation ofthe Na-K ATPase pump often results in a significant hypokalaemia
requiring replacement therapy.2
We report this case to illustrate the successful treatment with amiodarone of
ventricular fibrillation occurring in severe digoxin poisoning, and we think that
this antiarrhythmic should be employed as the drug of choice. Where cardiac
arrhythmia and hyperkalaemia are resistant to conventional therapy, digoxin-
specific antibody fragments are an extremely effective and in many cases life-
saving therapeutic intervention.
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